These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15331079

  • 1. Predicting drug response based on gene expression.
    Robert J, Vekris A, Pourquier P, Bonnet J.
    Crit Rev Oncol Hematol; 2004 Sep; 51(3):205-27. PubMed ID: 15331079
    [Abstract] [Full Text] [Related]

  • 2. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.
    Oncogene; 2005 Nov 17; 24(51):7542-51. PubMed ID: 16044152
    [Abstract] [Full Text] [Related]

  • 3. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.
    Breast Cancer Res Treat; 2006 Mar 17; 96(1):17-39. PubMed ID: 16322897
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of drug resistance.
    Longley DB, Johnston PG.
    J Pathol; 2005 Jan 17; 205(2):275-92. PubMed ID: 15641020
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacogenetics and pharmacogenomics of cancers].
    Robert J.
    Pathol Biol (Paris); 2004 Jul 17; 52(6):332-7. PubMed ID: 15261376
    [Abstract] [Full Text] [Related]

  • 6. Predicting cancer drug response by proteomic profiling.
    Ma Y, Ding Z, Qian Y, Shi X, Castranova V, Harner EJ, Guo L.
    Clin Cancer Res; 2006 Aug 01; 12(15):4583-9. PubMed ID: 16899605
    [Abstract] [Full Text] [Related]

  • 7. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
    Huang R, Wallqvist A, Thanki N, Covell DG.
    Pharmacogenomics J; 2005 Aug 01; 5(6):381-99. PubMed ID: 16103895
    [Abstract] [Full Text] [Related]

  • 8. Drug resistance in chemotherapy for breast cancer.
    Saeki T, Tsuruo T, Sato W, Nishikawsa K.
    Cancer Chemother Pharmacol; 2005 Nov 01; 56 Suppl 1():84-9. PubMed ID: 16273361
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T, Volm M.
    Pharmacol Ther; 2005 Aug 01; 107(2):155-76. PubMed ID: 15890408
    [Abstract] [Full Text] [Related]

  • 10. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.
    Richardson A, Kaye SB.
    Drug Resist Updat; 2005 Oct 01; 8(5):311-21. PubMed ID: 16233989
    [Abstract] [Full Text] [Related]

  • 11. Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer.
    Szakács G, Gottesman MM.
    Mol Interv; 2004 Dec 01; 4(6):323-5. PubMed ID: 15616161
    [Abstract] [Full Text] [Related]

  • 12. Predicting drug response and toxicity based on gene polymorphisms.
    Robert J, Morvan VL, Smith D, Pourquier P, Bonnet J.
    Crit Rev Oncol Hematol; 2005 Jun 01; 54(3):171-96. PubMed ID: 15890268
    [Abstract] [Full Text] [Related]

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 14. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J, Guo X, Qian CN, Schoumans J, Leeser B, Kort E, Cole A, Resau J, Bradford C, Carey T, Wennerberg J, Anderson H, Tennvall J, Teh BT.
    Clin Cancer Res; 2004 Dec 15; 10(24):8204-13. PubMed ID: 15623595
    [Abstract] [Full Text] [Related]

  • 15. DNA methylation and sensitivity to antimetabolites in cancer cell lines.
    Sasaki S, Kobunai T, Kitayama J, Nagawa H.
    Oncol Rep; 2008 Feb 15; 19(2):407-12. PubMed ID: 18202788
    [Abstract] [Full Text] [Related]

  • 16. [Genomic markers and anticancer chemotherapy].
    Nishiyama M.
    Gan To Kagaku Ryoho; 2008 Feb 15; 35(2):194-9. PubMed ID: 18281756
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.